Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use

Madhusmita Dhupal,1 Devasish Chowdhury2 1Department of Microbiology, Wonju College of Medicine, Yonsei University, Wonju 26426, Republic of Korea; 2Material Nanochemistry Laboratory, Physical Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, IndiaCorresponden...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dhupal M, Chowdhury D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	phytochemicals cancer therapeutics apoptosis cell cycle arrest chemo-preventive agents clinical trials. Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/5e36c489cb8043bdadb30ab5b0eb873f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5e36c489cb8043bdadb30ab5b0eb873f
record_format	dspace
spelling	oai:doaj.org-article:5e36c489cb8043bdadb30ab5b0eb873f2021-12-02T14:57:55ZPhytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use1178-2013https://doaj.org/article/5e36c489cb8043bdadb30ab5b0eb873f2020-11-01T00:00:00Zhttps://www.dovepress.com/phytochemical-based-nanomedicine-for-advanced-cancer-theranostics-pers-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Madhusmita Dhupal,1 Devasish Chowdhury2 1Department of Microbiology, Wonju College of Medicine, Yonsei University, Wonju 26426, Republic of Korea; 2Material Nanochemistry Laboratory, Physical Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, IndiaCorrespondence: Devasish ChowdhuryMaterial Nanochemistry Laboratory, Physical Sciences Division, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Garchuk, Guwahati 781035, IndiaTel +91 361 2912073Fax +91 361 2279909Email devasish@iasst.gov.inMadhusmita Dhupal Department of Microbiology, Wonju 26426, Republic of KoreaEmail dhupal25@gmail.comAbstract: In the current chapter, a new strategic compilation of phytochemicals with potent antitumor properties has been addressed, most importantly focusing on cell cycle arrest and apoptotic signaling mechanism. A promising approach in tumor prevention is to eliminate cancer cells preferably via cell cycle arrest and programmed cell death with lesser harm to neighboring normal cells. Cancer cells have a survival advantage to escape apoptosis and relentlessly divide to proliferate, gearing up the cell cycle process. Recently, the use of phytochemical-derived conjugated chemotherapeutic agents has increased dramatically owing to its biocompatibility, low cytotoxicity, low resistance, and dynamic physiochemical properties discriminating normal cells in the treatment of various cancer types. For decades, biomedical investigations have targeted cell cycle and apoptotic cell death mechanism as an effective cancer-killing tool for systemically assessing the potential biological interactions of functional phytocompounds compared to its synthetic counterparts during their complete life cycles from entry, biodistribution, cellular/molecular interactions to excretion. Newly emerging nanotechnology application in anticancer drug formulations has revolutionized cancer therapy. Tissue-specific phyto-nanomedicine plays a vital role in advanced cancer diagnostics using liposome, micelle, and nanoparticles as a precise and effective delivery vehicle. This chapter specifically focuses on the therapeutic phytomolecules approved by the Food and Drug Administration (FDA, USA) along with phyto-chemopreventives currently on clinical trials (Phase-I/II/III/IV). Besides, detailed coverage is given to the FDA-approved nanotechnology-based formulations only in the areas of cancer theranostics via cell cycle arrest and apoptotic pathways including present challenges and future perspectives.Keywords: phytochemicals, cancer therapeutics, apoptosis, cell cycle arrest, chemo-preventive agents, clinical trialsDhupal MChowdhury DDove Medical Pressarticlephytochemicalscancer therapeuticsapoptosiscell cycle arrestchemo-preventive agentsclinical trials.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 9125-9157 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	phytochemicals cancer therapeutics apoptosis cell cycle arrest chemo-preventive agents clinical trials. Medicine (General) R5-920
spellingShingle	phytochemicals cancer therapeutics apoptosis cell cycle arrest chemo-preventive agents clinical trials. Medicine (General) R5-920 Dhupal M Chowdhury D Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
description	Madhusmita Dhupal,1 Devasish Chowdhury2 1Department of Microbiology, Wonju College of Medicine, Yonsei University, Wonju 26426, Republic of Korea; 2Material Nanochemistry Laboratory, Physical Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, IndiaCorrespondence: Devasish ChowdhuryMaterial Nanochemistry Laboratory, Physical Sciences Division, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Garchuk, Guwahati 781035, IndiaTel +91 361 2912073Fax +91 361 2279909Email devasish@iasst.gov.inMadhusmita Dhupal Department of Microbiology, Wonju 26426, Republic of KoreaEmail dhupal25@gmail.comAbstract: In the current chapter, a new strategic compilation of phytochemicals with potent antitumor properties has been addressed, most importantly focusing on cell cycle arrest and apoptotic signaling mechanism. A promising approach in tumor prevention is to eliminate cancer cells preferably via cell cycle arrest and programmed cell death with lesser harm to neighboring normal cells. Cancer cells have a survival advantage to escape apoptosis and relentlessly divide to proliferate, gearing up the cell cycle process. Recently, the use of phytochemical-derived conjugated chemotherapeutic agents has increased dramatically owing to its biocompatibility, low cytotoxicity, low resistance, and dynamic physiochemical properties discriminating normal cells in the treatment of various cancer types. For decades, biomedical investigations have targeted cell cycle and apoptotic cell death mechanism as an effective cancer-killing tool for systemically assessing the potential biological interactions of functional phytocompounds compared to its synthetic counterparts during their complete life cycles from entry, biodistribution, cellular/molecular interactions to excretion. Newly emerging nanotechnology application in anticancer drug formulations has revolutionized cancer therapy. Tissue-specific phyto-nanomedicine plays a vital role in advanced cancer diagnostics using liposome, micelle, and nanoparticles as a precise and effective delivery vehicle. This chapter specifically focuses on the therapeutic phytomolecules approved by the Food and Drug Administration (FDA, USA) along with phyto-chemopreventives currently on clinical trials (Phase-I/II/III/IV). Besides, detailed coverage is given to the FDA-approved nanotechnology-based formulations only in the areas of cancer theranostics via cell cycle arrest and apoptotic pathways including present challenges and future perspectives.Keywords: phytochemicals, cancer therapeutics, apoptosis, cell cycle arrest, chemo-preventive agents, clinical trials
format	article
author	Dhupal M Chowdhury D
author_facet	Dhupal M Chowdhury D
author_sort	Dhupal M
title	Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
title_short	Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
title_full	Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
title_fullStr	Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
title_full_unstemmed	Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
title_sort	phytochemical-based nanomedicine for advanced cancer theranostics: perspectives on clinical trials to clinical use
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/5e36c489cb8043bdadb30ab5b0eb873f
work_keys_str_mv	AT dhupalm phytochemicalbasednanomedicineforadvancedcancertheranosticsperspectivesonclinicaltrialstoclinicaluse AT chowdhuryd phytochemicalbasednanomedicineforadvancedcancertheranosticsperspectivesonclinicaltrialstoclinicaluse
_version_	1718389326627209216

Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use

Ejemplares similares